Febuxsostat as a renoprotector in patients with chronic renal insufficiency

In the article presented the data about dependence of uricemia’s level and the subjective assessment of the quality of life in patients with end stage renal disease (ESRD) and an increase ofresidual functional renal reserve in 90 patients under the influence of febuxsostat at a dose of 40 mg are giv...

Full description

Bibliographic Details
Main Author: Z. V. Babenko
Format: Article
Language:English
Published: Kazimierz Wielki University 2019-02-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6863
_version_ 1818621646151352320
author Z. V. Babenko
author_facet Z. V. Babenko
author_sort Z. V. Babenko
collection DOAJ
description In the article presented the data about dependence of uricemia’s level and the subjective assessment of the quality of life in patients with end stage renal disease (ESRD) and an increase ofresidual functional renal reserve in 90 patients under the influence of febuxsostat at a dose of 40 mg are given. It has been proved that by reducing the level of uric acid, the residual functional renal reserve increases and the quality of life of patients improves (according to the questionnaire). This is best reflected in predialysis patients with ESRD. The data obtained allow febuxsostat consider to be effective urates-reductive therapy.
first_indexed 2024-12-16T18:12:35Z
format Article
id doaj.art-6706a34e1597423689dee976cc555538
institution Directory Open Access Journal
issn 2391-8306
language English
last_indexed 2024-12-16T18:12:35Z
publishDate 2019-02-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj.art-6706a34e1597423689dee976cc5555382022-12-21T22:21:44ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062019-02-019255956810.5281/zenodo.26513666106Febuxsostat as a renoprotector in patients with chronic renal insufficiencyZ. V. Babenko0The 10th Municipal Hospital, OdessaIn the article presented the data about dependence of uricemia’s level and the subjective assessment of the quality of life in patients with end stage renal disease (ESRD) and an increase ofresidual functional renal reserve in 90 patients under the influence of febuxsostat at a dose of 40 mg are given. It has been proved that by reducing the level of uric acid, the residual functional renal reserve increases and the quality of life of patients improves (according to the questionnaire). This is best reflected in predialysis patients with ESRD. The data obtained allow febuxsostat consider to be effective urates-reductive therapy.http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6863chronic kidney disease, hyperuricemia, uric acid, febuxsostat
spellingShingle Z. V. Babenko
Febuxsostat as a renoprotector in patients with chronic renal insufficiency
Journal of Education, Health and Sport
chronic kidney disease, hyperuricemia, uric acid, febuxsostat
title Febuxsostat as a renoprotector in patients with chronic renal insufficiency
title_full Febuxsostat as a renoprotector in patients with chronic renal insufficiency
title_fullStr Febuxsostat as a renoprotector in patients with chronic renal insufficiency
title_full_unstemmed Febuxsostat as a renoprotector in patients with chronic renal insufficiency
title_short Febuxsostat as a renoprotector in patients with chronic renal insufficiency
title_sort febuxsostat as a renoprotector in patients with chronic renal insufficiency
topic chronic kidney disease, hyperuricemia, uric acid, febuxsostat
url http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6863
work_keys_str_mv AT zvbabenko febuxsostatasarenoprotectorinpatientswithchronicrenalinsufficiency